The effect of atorvastatin on insulin sensitivity, glucose metabolism and hormonal and inflammatory parameters in women with polycystic ovary syndrome (PCOS). - Atorvastatin and PCOS

Active, not recruiting

• Conditions: Polycytic ovary syndrome (PCOS),

• Registration Number: EUCTR2006-003584-31-FI
• Lead Sponsor: Dept. Ob.Gyn, Univ Oulu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07-13
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

30-50-year old women with polycystic ovary syndrome (PCOS) and reliable non-hormonal birth control (IUD + condom or sterilisation).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Menopause, smokers, alcohol users, use of sexhormones or drugs that are known to affect lipid metabolism (3 months wash-out period required), history of active liver disease, liver/kidney/cardiac failure, muscular disease, pregnancy or lactation, allergy to atorvastatin.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified